INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [ ], 20[ ] by and between Carisma Therapeutics Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement.
CARISMA Therapeutics Inc. Nonstatutory Stock Option Agreement Granted Under 2017 Stock Incentive PlanNonstatutory Stock Option Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of March 7, 2023 (the “Effective Date”), by and between Carisma Therapeutics Inc., a Delaware corporation (the “Company”), and Richard Morris (the “Executive”) (together, the “Parties”).
Carisma Therapeutics Inc. Restricted Stock Unit Agreement Granted under the Amended and Restated 2014 Stock Incentive PlanRestricted Stock Unit Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Carisma Therapeutics Inc. STOCK OPTION AGREEMENTStock Option Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
CARISMA Therapeutics Inc. Incentive Stock Option Agreement Granted Under 2017 Stock Incentive PlanIncentive Stock Option Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of March 7, 2023 (this “Agreement”), is entered into by and among Sesen Bio, Inc., a Delaware corporation (“Parent”), and Computershare Inc. (“Computershare”) and its affiliate, Computershare Trust Company, N.A., together, as the Rights Agent.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 8th, 2023 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 7th day of March, 2023, by and among CARISMA Therapeutics Inc., a Delaware corporation (“Carisma”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
